Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice

Pharmacology Biochemistry and Behavior

Volumn 78, Issue 1, 2004, Pages 75-81

  De Luca, Grazia ^a   Di Giorgio, Rosa Maria ^a   Macaione, Salvatore ^a   Calpona, Pina Rita ^a   Costantino, Santa ^a   Di Paola, Eugenio Donato ^b   De Sarro, Angela ^a   Ciliberto, Gennaro ^b,c   De Sarro, Giovambattista ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c IRBM   (Italy)

Author keywords

Audiogenic seizures; Electroshock; Epilepsy; Interleukin 6; Neuroactive amino acids

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID RECEPTOR AFFECTING AGENT; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; INTERLEUKIN 6; TAURINE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; AMINO ACID BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDIOGENIC SEIZURE; BRAIN STEM; CEREBELLUM; CEREBELLUM CORTEX; CONTROLLED STUDY; DIENCEPHALON; DISEASE MODEL; ELECTRIC SHOCK; EVALUATION; HIPPOCAMPUS; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; SEIZURE SUSCEPTIBILITY; SPECIES COMPARISON;

ACOUSTIC STIMULATION; AGE FACTORS; ANIMALS; BRAIN; EPILEPSY, REFLEX; GENETIC PREDISPOSITION TO DISEASE; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; NEUROTRANSMITTER AGENTS;

EID: 2442716072     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.02.004     Document Type: Article

References (56)

1. Ali C., Nicole O., Docagne F., Lesne S., MacKenzie E.T., Nouvelot A., et al. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J. Cereb. Blood Flow Metab. 20:2000;956-966
2. Brennan T.J., Seeley W.W., Kilgard M., Schreiner C.E., Tecott L.H. Sound-induced seizures in serotonin 5-HT2C receptor mutant mice. Nat. Genet. 16:1997;387-390
3. Campbell I.L. Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology. Brain Res. Brain Res. Rev. 26:1998;327-336
4. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10061-10065
5. Carlson N.G., Wieggel W.A., Chen J., Bacchi A., Rogers S.W., Gahring L.C. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6 and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 163:1999;3963-3968
6. Chapman A.G., De Sarro G.B., Premachandra M., Meldrum B.S. Bidirectional effects of beta-carbolines in reflex epilepsy. Brain Res. Bull. 19:1987;337-346
7. Chiang C.S., Stalder A., Samimi A., Campbell I.L. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci. 16:1994;212-221
8. De Bock F., Dornand J., Rondouin G. Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. NeuroReport. 7:1996;1125-1129
9. De Sarro G.B., Croucher M.J., Meldrum B.S. Anticonvulsant actions of DS 103-282: pharmacological studies in rodents and the baboon, Papio papio. Neuropharmacology. 23:1984;525-530
10. De Sarro G.B., Nava F., Calapai G., De Sarro A. Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice. Antimicrob. Agents Chemother. 41:1997;427-434
11. De Sarro G., Russo E., Ferreri G., Bruzzese G., Flocco M.A., Donato Di Paola E., et al. Seizure susceptibility to various convulsant stimuli of knockout interleukin 6 mice. Pharmacol. Biochem. Behav. 2004;. [in press]
12. Engel J. Jr. Critical evaluation of animal models for localization-related epilepsies. Ital. J. Neurol. Sci. 16:1995;9-16
13. Engstrom F.L., Woodbury D.M. Seizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia. 29:1988;389-395
14. Engstrom F.L., White H.S., Kemp J.W., Woodbury D.M. Acute and chronic acetazolamide administration in DBA and C57 mice: effects of age. Epilepsia. 27:1986;19-26
15. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42:1984;1-11
16. Gadient R.A., Otten U.H. Interleukin-6 (IL-6) a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52:1997;379-390
17. Gale K. Chemoconvulsant seizure: advantages of focally-evoked seizure models. Ital. J. Neurol. Sci. 16:1995;17-25
18. Gidal B.E., Reiss W.G., Liao J.S., Pitterle M.E. Changes in IL-6 concentrations following epilepsy surgery: potential influence on carbamazepine pharmacokinetics. Ann. Pharmacother. 30:1996;545-546
19. Go T., Nakamura K. Frequent seizures with elevated IL-6 at the eruptive stage of exanthema subitum. Eur. Pediatr. Neurol. 6:2002;221-223
20. Gundersen V., Chaudhry F.A., Bjaalie J.G., Fonnum F., Ottersen O.P., Storm-Mathisen J. Synaptic vesicular localization and exocytosis of L-aspartate in excitatory nerve terminals: a quantitative immunogold analysis in rat hippocampus. J. Neurosci. 18:1998;6059-6070
21. Hall C.S. Genetic differences in fatal audiogenic seizures. J. Hered. 38:1947;3-6
22. Higuchi M., Ito T., Imai Y., Iwaki T., Hattori M., Kohsaka S., et al. Expression of the alpha2-macroglobulin-encoding gene in rat brain and cultured astrocytes. Gene. 141:1994;155-162
23. Hopkins S., Rothwell N. Cytokines and the nervous system: I. Expression and recognition. Trends Neurosci. 18:1995;83-88
24. Ichiyama T., Nishikawa M., Yoshitomi T., Hayashi T., Furukawa S. Tumor necrosis factor-alpha IL-1 beta, and IL-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis/ encephalopathy. Neurology. 50:1998;407-411
25. Ichiyama T., Okada K., Lipton J.M., Matsubara T., Hayashi T., Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res. 857:2000;246-251
26. Kash S.F., Johnson R.S., Tecott L.H., Noebels J.L., Mayfield R.D., Hanahan D., et al. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4060-4065
27. Kimura M., Tasaka M., Sejima H., Takusa Y., Ichiyama T., Yamaguchi S. Hemiconvulsion-hemiplegia syndrome and elevated IL-6: case report. J. Child Neurol. 17:2002;705-707
28. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-111
29. Malas S., Postlethwaite M., Ekonomou A., Whalley B., Nishiguchi S., Wood H., et al. Sox1-deficient mice suffer from epilepsy associated with abnormal ventral forebrain development and olfactory cortex hyperexcitability. Neuroscience. 119:2003;421-432
30. Martinez-Hernandez A., Bell K.P., Norenberg M.D. Glutamine synthetase: glial localization in brain. Science. 195:1977;1356-1358
31. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messanger RNA levels of IL-1 beta, Il-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176:1991;593-598
32. Misawa H., Sherr E.H., Lee D.J., Chetkovich D.M., Tan A., Schreiner C.E., et al. Identification of a monogenic locus (jams1) causing juvenile audiogenic seizures in mice. J. Neurosci. 22:2002;10088-10093
33. Musumeci S.A., Bosco P., Calabrese G., Bakker C., De Sarro G.B., Elia M., et al. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia. 41:2000;19-23
34. Neumann P.E., Collins R.L. Genetic dissection of susceptibility to audiogenic seizures in inbred mice. Proc. Natl. Acad. Sci. U. S. A. 88:1991;5408-5412
35. Neumann P.E., Seyfried T.N. Mapping of two genes that influence susceptibility to audiogenic seizures in crosses of C57BL/6J and DBA/2J mice. Behav. Genet. 20:1990;307-323
36. Noebels J.L. A single gene error of noradrenergic axon growth synchronizes central neurones. Nature. 310:1984;409-411
37. Noebels J.L. Exploring new gene discoveries in idiopathic generalized epilepsy. Epilepsia. 44(Suppl. 2):2003;16-21
38. Peltola J., Hurme M., Miettinen A., Keranen T. Elevated levels of interleukin-6 occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 31:1998;129-133
39. Peltola J., Palmio J., Korhonen L., Suhonen J., Miettinen A., Hurme M., et al. Interleukin-6 and interleukin-1 receptors antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 41:2000;205-211
40. Peltola J., Laaksonen J., Haapala A.M., Hurme M., Rainesalo S., Kerano T. Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure. 11:2000;44-46
41. Penkowa M., Molinero A., Carrasco J., Hidalgo J. IL-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience. 102:2001;805-818
42. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13:1994;1189-1196
43. Rise M.L., Frankel W.N., Coffin J.M., Seyfried T.N. Genes for epilepsy mapped in the mouse. Science. 253:1991;669-673
44. Samland H., Huitron-Resendiz S., Masliah E., Criado J., Henriksen S.J., Campbell I.L. Profound increase in sensitivity to glutamatergic - but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J. Neurosci. Res. 73:2003;176-187
45. SAS Institute SAS/STAT guide for personal computers, version 6 edition. 1987;SAS Institute, Cary (NC)
46. Seyfried T.N., Glaser G.H. A review of mouse mutants as genetic models of epilepsy. Epilepsia. 26:1985;143-150
47. Steffensen S.C., Campbell I.L., Henriksen S.J. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 652:1994;149-153
48. Straussberg R., Amir J., Harel L., Punsky I., Bessler H. Pro- and anti-inflammatory cytokines in children with febrile convulsions. Pediatr. Neurol. 24:2001;49-53
49. Swinyard E.A., Woodhead J.M. Experimental detection, quantification and evaluation of anticonvulsants. Woodbury D.M., Penry J.K., Pippinger C.E. Epileptic drugs. 1982;111-126 Raven Press, New York
50. Sykes C.C., Horton R.W. Cerebral glutamic acid decarboxylase activity and γ-aminobutyric acid concentrations in mice susceptible or resistant to audiogenic seizures. J. Neurochem. 39:1982;1489-1491
51. Tansey F.A., Farooq M., Cammer W. Glutamine synthetase in oligodendrocytes and astrocytes: new biochemical and immunocytochemical evidence. J. Neurochem. 56:1991;266-272
52. Toulmond S., Vige X., Fage D., Benavides J. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. 144:1992;49-52
53. Upton N., Stratton S. Recent developments from genetic mouse models of seizures. Curr. Opin. Pharmacol. 3:2003;19-26
54. Van den Berg C.J., Garfinkel D. A stimulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. Biochem. J. 123:1971;211-218
55. Virta M., Hurme M., Helminen M. Increased plasma levels of pro- and anti-inflammatory cytokines with febrile seizures. Epilepsia. 43:2002;920-923
56. Yamada M., Hatanaka H. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643:1994;173-180